Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Antibiotic Treatment of Gulf War Veterans' Illnesses

This study has been completed.
United States Department of Defense
Information provided by:
VA Office of Research and Development Identifier:
First received: December 29, 2000
Last updated: January 20, 2009
Last verified: February 2007
In 1990 and 1991, the U.S. deployed approximately 700,000 troops to the Persian Gulf to liberate Kuwait from Iraqi occupation. While there were few casualties associated with the Gulf War, many individuals returned from this conflict with unexplained symptoms and illnesses. This constellation of symptoms has been termed Gulf War Veterans' Illnesses (GWI). Although several explanations have been offered as to the cause of GWI, none of the putative etiologic agents or conditions is currently supported by sufficient evidence. One explanation that has received fairly widespread attention is systemic Mycoplasma fermentans infection. It is the purpose of this study to determine if antibiotic treatment directed against Mycoplasma species (i.e. doxycycline) will improve functioning and symptoms in deployed Gulf War veterans with GWI.

Condition Intervention Phase
Persian Gulf Syndrome
Mycoplasma Infections
Drug: Doxycycline (200mg/day) or Placebo
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Official Title: CSP #475 - Persian Gulf - Antibiotic Treatment Trial of Gulf War Veterans' Illnesses

Resource links provided by NLM:

Further study details as provided by VA Office of Research and Development:

Estimated Enrollment: 450
Study Start Date: January 1999
Estimated Study Completion Date: October 2001
  Show Detailed Description


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
All veterans deployed to the Gulf War between August, 1990 and August, 1991 having at least two of the following symptoms: Fatigue, musculoskeletal pain or neurocognitive dysfunction. Mycoplasma positive
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00007735

  Hide Study Locations
United States, Alabama
Vamc - Birmingham, Al
Birmingham, Alabama, United States, 35233
United States, California
Naval Health Research Center Merchant Illness Divi
San Diego, California, United States, 92152
United States, District of Columbia
Uniformed Services University Department of Psychi
Washington, District of Columbia, United States, 20307-5001
United States, Georgia
Vamc - Augusta, Ga
Augusta, Georgia, United States, 30904-6285
United States, Illinois
Vamc - Hines,Il
Hines, Illinois, United States, 60141
United States, Louisiana
Vamc - New Orleans, La
New Orleans, Louisiana, United States, 70146
United States, Massachusetts
Vamc - Boston, Ma
Boston, Massachusetts, United States, 02130
United States, Nebraska
Vamc - Omaha, NE
Omaha, Nebraska, United States, 68105
United States, New Hampshire
Vamc - Manchester,Nh
Manchester, New Hampshire, United States, 03103
United States, New Jersey
Vamc - East Orange, Nj
East Orange, New Jersey, United States, 07018
United States, New Mexico
Vamc - Albuquerque, Nm
Albuquerque, New Mexico, United States, 87108
United States, New York
Vamc - Albany, Ny
Albany, New York, United States, 12208
Vamc - Bronx,Ny
Bronx, New York, United States, 10468
Vamc - Brooklyn, Ny
Brooklyn, New York, United States, 11209
United States, North Carolina
Vamc - Durham, Nc
Durham, North Carolina, United States, 27705
United States, North Dakota
Vamc - Fargo, Nd
Fargo, North Dakota, United States, 58102-2498
United States, Ohio
Vamc - Dayton, Oh
Kettering, Ohio, United States, 45429
United States, Oklahoma
Vamc - Oklahoma City, Ok
Oklahoma City, Oklahoma, United States, 73104
United States, Pennsylvania
Vamc - Philadelphia, Pa
Philadelphia, Pennsylvania, United States, 19104
United States, Rhode Island
Vamc - Providence, Ri
Providence, Rhode Island, United States, 02908-4799
United States, South Carolina
Vamc - Charleston, Sc
Charleston, South Carolina, United States, 29401-5799
United States, Tennessee
Vamc - Nashville, Tn
Nashville, Tennessee, United States, 37212-2637
United States, Texas
Vamc - Houston, Tx
Houston, Texas, United States, 77030-4298
United States, Vermont
Vamc - White River Junction
White River Junction, Vermont, United States, 05009
United States, Virginia
Vamc - Richmond, Va
Richmond, Virginia, United States, 23249
United States, Wisconsin
Vamc - Milwaukee, Wi
Milwaukee, Wisconsin, United States, 53295
Puerto Rico
Vamc - San Juan, Pr
San Juan, Puerto Rico, 00927
Sponsors and Collaborators
VA Office of Research and Development
United States Department of Defense
  More Information Identifier: NCT00007735     History of Changes
Other Study ID Numbers: 475
Study First Received: December 29, 2000
Last Updated: January 20, 2009

Keywords provided by VA Office of Research and Development:
antibiotic treatment
mycoplasma species
Gulf War Veterans' Illnesses (GWI)
mycoplasma positive
Gulf War Syndrome

Additional relevant MeSH terms:
Mycoplasma Infections
Persian Gulf Syndrome
Lung Diseases
Respiratory Tract Diseases
Pleural Diseases
Respiratory Tract Infections
Mycoplasmatales Infections
Gram-Negative Bacterial Infections
Bacterial Infections
Occupational Diseases
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Antitubercular Agents
Antiprotozoal Agents
Antiparasitic Agents processed this record on April 28, 2017